ASHP is committed to bringing you the most relevant COVID-19 updates as we navigate these unprecedented times.
- Today, President Trump’s Coronavirus Task Force issued new recommendations to include limiting social gatherings to no more than 10 people over the next 15 days.
- The first participant in a clinical trial for a vaccine to protect against COVID-19 received an experimental dose on Monday.
- ASHP continues to monitor for impact to drug shortages.
- ASHP sent a letter to Vice President Mike Pence urging the Trump Administration to take immediate steps to maximize pharmacist engagement in COVID-19 preparedness and response efforts. We also asked that decisive action by the Centers for Medicare & Medicaid Services be taken to remove barriers to pharmacists’ patient care services.
- We are also closely monitoring the impact to personal protective equipment supply and will report results of our survey later this week.
- We have made AHFS Drug Information available to the public through May 31. You may access this resource with the username “ahfs@ashp.org” and password “covid-19.”
We encourage you to bookmark ASHP’s COVID-19 Resource Center, which serves as a clearinghouse for more information on COVID-19.
New: COVID-19 Pandemic Assessment Tool
ASHP has released its COVID-19 Pandemic Assessment Tool for Health-System Pharmacy Departments, which is intended to assist in COVID-19 pandemic planning efforts in departments of pharmacy and to foster pharmacist involvement in preparedness at the institutional and community levels.
